US loss of exclusivity · Other
Vabysmo
Roche
2034
US biosimilars from
2025
Today: 2026
2037
2025 worldwide sales
≈$4.9B
Date basis
Patent-expiry estimate
US biosimilars
No US filing found
Pharma Patent Cliff
by readouts.io
Data checked 8 October 2026 ·
Full Vabysmo timeline →